RSK

RSK inhibitors act on p90 ribosomal S6 kinases (RSKs), four effectors of growth factor signaling. Extracellular signal-regulated kinases 1 and 2 (ERK1, ERK2) activate RSK1 to RSK4 at the end of the mitogen-activated protein kinase (MAPK) cascade. Each RSK has two kinase domains, and the C-terminal domain switches on the N-terminal domain that phosphorylates substrates. RSK substrates regulate transcription, protein synthesis, cell survival and cell motility. BI-D1870 and LJH685 occupy the ATP site of the N-terminal domain in all four isoforms. FMK targets the C-terminal domain, and SL 0101-1 is a flavonoid glycoside that inhibits RSK1 and RSK2. PF 4708671 and LY-2584702 instead inhibit the related p70 S6 kinase 1 (S6K1).

Items 26-29 of 29

  • Bisindolylmaleimide V
    Cat. No.
    A65853

    Bisindolylmaleimide V

    Synonyms: BIM V

    Bisindolylmaleimide V is a cell-permeable inhibitor targeting S6K (p70s6k/p85s6k), a key regulator in the mTOR signaling pathway. With an IC50 of 8 µM, it effectively blocks S6K activation in response to mitogen stimuli. This compound is essential for studying the role of S6K in cellular processes and assessing pathways related to cell growth and metabolism.

    1 mg
    $55.00
    5 mg
    $135.00
    All 9 sizes
  • RSK2-IN-2
    Cat. No.
    A65859

    RSK2-IN-2

    RSK2-IN-2 is a reversible covalent inhibitor targeting the RPS6KA3 (RSK2) kinase. This compound also exhibits inhibitory activity against MSK1, MSK2, and RSK3. RSK2-IN-2 is useful for studies investigating signal transduction pathways, particularly those involving the RSK family of kinases, and can aid in the exploration of therapeutic strategies in oncology and related fields.

    25 mg
    $1,800.00
    50 mg
    $2,285.00
    All 3 sizes
  • RSK2-IN-3
    Cat. No.
    A65860

    RSK2-IN-3

    RSK2-IN-3 is a reversible covalent inhibitor of RPS6KA3 (RSK2) kinase. This compound effectively modulates RSK2 activity, which is implicated in various cellular processes including cell proliferation and survival. RSK2-IN-3 is primarily used in research studies focused on cancer and other diseases related to aberrant RSK signaling pathways.

    25 mg
    $1,800.00
    50 mg
    $2,285.00
    All 3 sizes
  • RSK2-IN-4
    Cat. No.
    A65861

    RSK2-IN-4

    RSK2-IN-4 is a selective RSK2 inhibitor that demonstrates an inhibition rate of 13.73% at a concentration of 10 μM. This compound targets the ATP-binding site within the N-terminal kinase domain of RSK2, with the electron-donating group positioned at the 4-position of the phenyl ring playing a critical role in its inhibitory efficacy. RSK2-IN-4 serves as a valuable tool for researchers investigating RSK2's role in signaling pathways and its implications in various cellular processes.

    25 mg
    $140.00
    50 mg
    $200.00
    All 5 sizes

Items 26-29 of 29

Added to your cart

View Cart Checkout

    Loading...